SEC Company Response from Mylan International Holdings, Inc. (CIK 0001343309) — Dec 15, 2005
Mylan International Holdings, Inc. (CIK 0001343309)
Date: Dec. 15, 2005 · CIK: 0001343309 · Accession: 0000950123-05-014762
AI Filing Summary & Sentiment
File numbers found in text: 333-129823
Letter
LETTER TO THE S.E.C.
MYLAN LABORATORIES INC.
1500 Corporate Drive
Canonsburg, Pennsylvania 15317
Telephone: (724) 514-1800
December 14, 2005
VIA FACSIMILE AND EDGAR TRANSMITTAL
Securities and Exchange Commission
100 F Street, N.E., Mail Stop 6010
Washington, D.C. 20549
Attention: Sonia Barros
RE:
Mylan Laboratories Inc.
Registration Statement on Form S-4 (No. 333-129823)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), respectfully requests that the effective date of its Registration Statement on Form S-4 (No. 333-129823) be accelerated by the Securities and Exchange Commission (the “Commission”) to 4:00 p.m. Eastern Time on Friday, December 16, 2005, or as soon thereafter as practicable.
Pursuant to your letter informing the Company of the Commission’s decision to limit its review of the Registration Statement, we hereby acknowledge that should the Commission or its staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing. In addition, the Company acknowledges that the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing. Moreover, the Company acknowledges that it may not assert the Commission’s limited review action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
We request that we be notified of such effectiveness by a telephone call to Andrea Nicolas at (212) 735-3416 and that such effectiveness be confirmed in writing.
Very truly yours,
MYLAN LABORATORIES INC.
Show Raw Text
CORRESP
1
filename1.htm
LETTER TO THE S.E.C.
MYLAN LABORATORIES INC.
1500 Corporate Drive
Canonsburg, Pennsylvania 15317
Telephone: (724) 514-1800
December 14, 2005
VIA FACSIMILE AND EDGAR TRANSMITTAL
Securities and Exchange Commission
100 F Street, N.E., Mail Stop 6010
Washington, D.C. 20549
Attention: Sonia Barros
RE:
Mylan Laboratories Inc.
Registration Statement on Form S-4 (No. 333-129823)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mylan Laboratories Inc., a
Pennsylvania corporation (the “Company”), respectfully requests that the effective date of its
Registration Statement on Form S-4 (No. 333-129823) be accelerated by the Securities and Exchange
Commission (the “Commission”) to 4:00 p.m. Eastern Time on Friday, December 16, 2005, or as soon
thereafter as practicable.
Pursuant to your letter informing the Company of the Commission’s decision to limit its review
of the Registration Statement, we hereby acknowledge that should the Commission or its staff,
acting pursuant to delegated authority, declare the filing effective, it does not foreclose the
Commission from taking any action with respect to the filing. In addition, the Company
acknowledges that the action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company from its full
responsibility for the adequacy and accuracy of the disclosure in the filing. Moreover, the
Company acknowledges that it may not assert the Commission’s limited review action as a defense in
any proceeding initiated by the Commission or any person under the federal securities laws of the
United States.
We request that we be notified of such effectiveness by a telephone call to Andrea Nicolas at
(212) 735-3416 and that such effectiveness be confirmed in writing.
Very truly yours,
MYLAN LABORATORIES INC.
By:
/s/ Edward J. Borkowski
Name: Edward J. Borkowski
Title: Chief Financial Officer